Please use this identifier to cite or link to this item: https://doi.org/10.1007/s0054010050239
Title: Prevention of succinylcholine-induced myalgia with lidocaine pretreatment
Authors: Lee, T.-L. 
Aw, T.-C. 
Keywords: lidocaine pretreatment
post-succinylcholine myalgia
Issue Date: Jul-1991
Citation: Lee, T.-L., Aw, T.-C. (1991-07). Prevention of succinylcholine-induced myalgia with lidocaine pretreatment. Journal of Anesthesia 5 (3) : 239-246. ScholarBank@NUS Repository. https://doi.org/10.1007/s0054010050239
Abstract: We studied the effects of 3 mg·kg -1 lidocaine iv on the succinylcholine (SCh)-induced myalgia in 94 un premedicated ambulant patients undergoing dilatation and curettage of the uterus. The post-SCh myalgia was confirmed through interview by telephone. The data were correlated with the degree of fasciculation and changes in the serum electrolytes and creatine kinase (CK) levels following SCh administration. Pretreatment with lidocaine, 3 mg·kg -1 iv, significantly reduced the incidence of myalgia from 40.4% of control group to 12.8% of lidocaine-treated group, but not the CK levels. The severity of myalgia was not related to the intensity of fasciculation assessed by visual observation. The pretreatment with lidocaine had no untoward effect on the circulation, although the peak arterial and peak venous lidocaine levels achieved were 29.6±23 μg·ml -1 and 10.1±3.3 μg·ml -1 respectively. These findings indicated that the pretreatment with lidocaine, 3 mg·kg -1 iv, was effective in prevention of SCh-induced myalgia. © 1991 Japanese Society of Anesthesiologists.
Source Title: Journal of Anesthesia
URI: http://scholarbank.nus.edu.sg/handle/10635/129928
ISSN: 09138668
DOI: 10.1007/s0054010050239
Appears in Collections:Staff Publications

Show full item record
Files in This Item:
There are no files associated with this item.

SCOPUSTM   
Citations

3
checked on Oct 14, 2018

Page view(s)

16
checked on Sep 28, 2018

Google ScholarTM

Check

Altmetric


Items in DSpace are protected by copyright, with all rights reserved, unless otherwise indicated.